Abstract: A percutaneous medication device, comprising a syringe to be filled with medical liquid and a needle formation attached to a leading-end of the syringe is provided. The needle formation comprises a needle formation body, from the surface of which a needle projects and a cover portion covers a leading-end of the needle formation body. The needle is inserted into a through-hole formed at the leading-end of the needle formation body and fixed by a fixation member. The needle formation body is mated to the cover portion, a space is formed between an inner surface of the cover portion and the leading-end of the needle formation body, and the needle projects from the leading-end surface of the cover portion through a needle insertion hole formed at the leading-end of the cover portion.

Abstract: A drug solution injection needle is provided that can not only inject a drug solution from multiple locations, but also restrict the depth of puncture by injection needles while preventing an observable wheal from being unlikely to form. The drug solution injection needle has multiple injection needles and a needle support for supporting the plurality of injection needles. The needle support has: a needle protruding surface from which the multiple injection needles protrude out; and an abutment fragment, which is formed in the needle protruding surface and abuts the skin to obstruct the multiple injection needles from entering the skin when the multiple injection needles have entered the skin to a predetermined depth. The abutment section is provided away from the injection needles such that an observable wheal is formed around each of the multiple injection needles.

Abstract: A percutaneous medication device according to the present invention comprises: a syringe into which a medical liquid is filled; and a needle formation attached to a tip of the syringe; where: the needle formation comprises a plurality of needles protruding from a surface of a tip of the needle formation; a tip of the needle is cut diagonally with respect to the longitudinal direction of the needle; a discharge opening formed at the tip of each needle is facing substantially opposite from the center direction of the needle formation; and a pitch between the adjacent needles is 1 mm to 10 mm.

Abstract: The transdermal administration device of the present invention includes: a needle support with a plurality of microneedles formed at a tip portion thereof; a holder with the needle support placed therein, allowing the needle support to protrude itself therefrom and retract therein; and a cap for covering the microneedles, and further includes: a spring member placed between the needle support and the holder, for biasing the needle support in a protruding direction; an engaging portion at a base of the needle support; and an engaged portion capable of engaging the engaging portion, formed in the holder, where the engaging portion of the needle support can be locked with the engaged portion of the holder when the needle support is retracted in the holder.

Abstract: A percutaneous medication device, comprising a syringe to be filled with medical liquid and a needle formation attached to a leading-end of the syringe is provided. The needle formation comprises a needle formation body, from the surface of which a needle projects and a cover portion covers a leading-end of the needle formation body. The needle is inserted into a through-hole formed at the leading-end of the needle formation body and fixed by a fixation member. The needle formation body is mated to the cover portion, a space is formed between an inner surface of the cover portion and the leading-end of the needle formation body, and the needle projects from the leading-end surface of the cover portion through a needle insertion hole formed at the leading-end of the cover portion.

Abstract: The transdermal administration device of the present invention includes: a needle support with a plurality of microneedles formed at a tip portion thereof; a holder with the needle support placed therein, allowing the needle support to protrude itself therefrom and retract therein; and a cap for covering the microneedles, and further includes: a spring member placed between the needle support and the holder, for biasing the needle support in a protruding direction; an engaging portion at a base of the needle support; and an engaged portion capable of engaging the engaging portion, formed in the holder, where the engaging portion of the needle support can be locked with the engaged portion of the holder when the needle support is retracted in the holder.

Abstract: The transdermal administration device of the present invention includes: a device body including a needle form body, which includes a plurality of microneedles formed on a surface thereof and is provided with a fluid passage hole through the front surface to a back surface thereof, and a medical fluid filling section for providing a medical fluid to the back surface of the needle form body; a stratum corneum peeling system; and a connection section for connecting the device body and the stratum corneum peeling system, where the stratum corneum peeling system is connected to the device body by the connection section such that the microneedles of the needle form body of the device body are positioned in an area of a skin surface in which a stratum corneum is peeled by the stratum corneum peeling system.

Abstract: An injection molding apparatus for producing a molded form having a thin thickness portion through injection molding, comprising: a metal mold; a cavity formed in the metal mold for molding the molded form; a degassing hole formed in a portion of the metal mold corresponding to the thin thickness portion of the molded form; a degassing pin inserted in the degassing hole and fixed thereat, the degassing pin being longitudinally divided into at least two divisional parts; whereby gas in the cavity is forcedly exhausted not only through a first air gap between an inner surface of the degassing hole and an outside surface of the degassing pin but also through a second air gap in an abutment portion between the divisional parts of the degassing pin.